Skip to main content
OTCMKTS:HBPCF

Helix BioPharma Short Interest Ratio and Short Volume

$0.76
0.00 (0.00 %)
(As of 05/12/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.76
$0.76
50-Day Range
$0.67
$0.76
52-Week Range
$0.22
$1.01
VolumeN/A
Average Volume1,665 shs
Market Capitalization$107.80 million
P/E RatioN/A
Dividend YieldN/A
Beta0.04

Short Interest

Helix BioPharma (OTCMKTS:HBPCF) Short Interest Data

Current Short Volume100 shares
Previous Short Volume200 shares
Change Vs. Previous Month-50.00%
Dollar Volume Sold Short$72.01
Short Interest Ratio / Days to Cover0.2
Last Record DateApril, 15 2021
Outstanding Shares141,133,000 shares
Percentage of Shares Shorted0.00%
Today's Trading Volume0 shares
Average Trading Volume1,665 shares
Today's Volume Vs. Average-100.00%

Short Interest Over Time


Helix BioPharma (OTCMKTS:HBPCF) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/2021100 shares $72.01 -50.0%N/A0.2$0.72
3/31/2021200 shares $137.22 -66.7%N/A0.5$0.69
3/15/2021600 shares $391.50 -40.0%N/A0.1$0.65
2/26/20211,000 shares $589.70 +66.7%N/A2.5$0.59
2/12/2021600 shares $441.42 -53.9%N/A0.3$0.74
1/29/20211,300 shares $980.59 +1,200.0%N/A1.6$0.75
12/31/2020100 shares $29.26 No ChangeN/A0.1$0.29
9/15/202011,000 shares $3,968.80 No ChangeN/A3.4$0.36
8/14/20203,500 shares $1,336.65 No ChangeN/A1.8$0.38
6/30/2020100 shares $55.00 -75.0%N/A0.3$0.55
6/15/2020400 shares $260.00 No ChangeN/A0.7$0.65

Helix BioPharma (OTCMKTS:HBPCF) Short Interest FAQ

speech bubbles
speech bubbles











What is Helix BioPharma's current short interest?

Short interest is the volume of Helix BioPharma shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 100 shares of HBPCF short.

Is Helix BioPharma's short interest increasing or decreasing?

Helix BioPharma saw a decrease in short interest during the month of April. As of April 15th, there was short interest totaling 100 shares, a decrease of 50.0% from the previous total of 200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Helix BioPharma's short interest compare to its competitors?

0.00% of Helix BioPharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Helix BioPharma: Provention Bio, Inc. (0.00%), Geron Co. (0.00%), Forte Biosciences, Inc. (52.34%), Akouos, Inc. (19.72%), TherapeuticsMD, Inc. (0.00%), ANI Pharmaceuticals, Inc. (5.53%), 89bio, Inc. (0.00%), Cue Biopharma, Inc. (0.00%), Flexion Therapeutics, Inc. (0.00%), and Sesen Bio, Inc. (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Analog Devices, Inc. ($5.85 billion), Aon plc ($5.61 billion), Charter Communications, Inc. ($5.44 billion), Snap Inc. ($3.49 billion), Airbnb, Inc. ($3.35 billion), Peloton Interactive, Inc. ($2.53 billion), ViacomCBS Inc. ($2.48 billion), Expedia Group, Inc. ($2.39 billion), The Kroger Co. ($2.26 billion), and Nuance Communications, Inc. ($2.18 billion). View all of the most shorted stocks.

What does it mean to sell short Helix BioPharma stock?

Short selling HBPCF is an investing strategy that aims to generate trading profit from Helix BioPharma as its price is falling. To short Helix BioPharma stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Helix BioPharma will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Helix BioPharma?

A short squeeze for Helix BioPharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HBPCF, which in turn drives the price of the stock up even further.

How often is Helix BioPharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HBPCF, twice per month. The most recent reporting period available is April, 15 2021.



This page was last updated on 5/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.